The Top 25 Women Leaders in Medical Devices of 2023

The Top 25 Women Leaders in Medical Devices of 2023

The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Medical Devices of 2023. Technology is advancing at a rapid pace across industries, and perhaps nowhere is that more true than in the medical device market. In fact, according to Fortune Business Insights, the global market is projected to grow from roughly $495 billion in 2022 to nearly $719 billion by 2029 at a CAGR of 5.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. There is intense competition in the market, and the women on this year’s list and the companies they represent have found success innovating across a range of specialties, from insulin management systems to regenerative technologies, electrotherapy, and wireless surgical solutions.

Some of the distinguished leaders on this year’s list include Tania Saison, SVP and CCO/CRO of Edwards Lifesciences, who oversees the company’s Global Integrity Program, which establishes a comprehensive framework for ensuring compliance with applicable laws, regulations, and standards of conduct. Meanwhile, Jennifer Ernst, CEO of Tivic Health, built her company from founding to IPO in 5 years and put an award-winning medical device into market within 3 years. And Manisha Shah-Bugaj, COO of Activ Surgical, oversees the ongoing development and commercialization of the company’s products, including ActivSight™ Intelligent Light, which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.

The awardees on this year’s list lead from a range of positions, from President and CEO to SVP, EVP, and COO. What they have in common is their dedication to innovation in the medical device space, bringing revolutionary new devices to market and improving the lives of patients and clinicians alike. Please join us in celebrating The Top 25 Women Leaders in Medical Devices of 2023.

 

1. Tania Saison
Company: Edwards Lifesciences
Title: Senior Vice President and Chief Compliance Officer/Chief Responsibility Officer

Tania Saison is Senior Vice President and Chief Compliance Officer/Chief Responsibility Officer for Edwards Life Sciences, the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. As CRO, Saison oversees the company’s Global Integrity Program with unwavering support from the Board of Directors and executive leadership. The program establishes a comprehensive framework for ensuring compliance with applicable laws, regulations, and standards of conduct, and reinforces Edwards’ culture of integrity and ethics. Saison is a member of the global senior leadership team.

Prior to Edwards, Saison served as VP and Chief Compliance Officer for Agilent Technologies. She got her start at Agilent as Senior Compliance Counsel. Previously, she was Assistant General Counsel and Head of Global Compliance for Beckman Coulter, Senior Counsel for Diageo plc, and served as an attorney for Hunton & Williams and Dewey Ballantine LLP. Saison earned her JD from Columbia Law School, her MBA from Harvard Business School, and her Bachelor of Arts in history from Columbia University.

 

2. Simona Serban
Company: Fresenius Medical Care
Title: Chief Operating Officer

Simona Serban is based in Bucharest, Romania. She currently serves as the Chief Operating Officer of Fresenius Medical Care, the world’s leading provider of products and services for individuals with kidney diseases. Fresenius aims to create a future worth living for chronically and critically ill patients — worldwide and every day. Thanks to the company’s decades of experience in dialysis, its innovative research, and its value-based care approach, it is helping patients enjoy the very best quality of life.

Prior to her COO role, Serban held assignments of increasing responsibility in the healthcare industry. This includes stints serving as a customer solutions manager and sales representative for Merck Sharp & Dohme Romania SRL. Her areas of expertise include pharmaceutical sales, product launch, market analysis, marketing management, and hospital sales, among others. She holds a degree from the Universitatea Alexandru Ioan Cuza, which is located in Iasi, Romania.

 

3. Aviva McPherron
Company: NuVasive
Title: Chief Information Officer and Senior Vice President of IT

Aviva McPherron serves as NuVasive’s Chief Information Officer and Senior Vice President of IT, and is responsible for the company’s information technology organization. NuVasive is committed to transforming surgery, advancing care, and changing lives through less invasive, procedurally integrated solutions. Since its inception in 1999, it has continually outperformed the market as the largest, spine-focused company in the world. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.

McPherron’s previous roles include VP of Enterprise Applications and Senior Director of Business Solutions. Before joining NuVasive, she was Director of Operations for Tapestry Solutions, a Boeing Company, and has held multiple technical leadership positions delivering transformative solutions. McPherron holds a Bachelor of Science in mechanical engineering from Stanford University.

 

4. Elizabeth Sebern McCombs
Company: BD
Title: Executive Vice President and Chief Technology Officer

Elizabeth Sebern McCombs serves as Executive Vice President and Chief Technology Officer of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, she is responsible for leading all R&D activities for BD, advancing new product innovation and development from early-stage concepts through launch, and sustaining the current product portfolio. She is also a member of the BD Executive Leadership Team.

McCombs joined BD in 2019 as the Senior Vice President, R&D for the BD Medical Segment, where she co-led the segment portfolio strategy and growth acceleration initiatives. Prior to joining BD, she spent more than 20 years at Johnson & Johnson (J&J), most recently as Vice President, R&D for Ethicon, J&J’s surgical device franchise. Aside from her technical credentials, McCombs has been recognized for her work driving inclusion and diversity efforts, including the support and mentorship of fellow female professionals. She holds an MBA from the University of Pennsylvania’s Wharton School of Business and both a Master of Science and Bachelor of Science in mechanical engineering from the Massachusetts Institute of Technology.

 

5. Niamh Pellegrini
Company: Nevro
Title: Chief Commercial Officer

Niamh Pellegrini currently serves as Chief Commercial Officer for Nevro, a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Pellegrini is a proven commercial leader with over 30 years of experience in the healthcare industry. Prior to joining Nevro, she was Vice President of Global Commercial Operations for Abbott Vascular.

Before Abbott, Pellegrini served as CEO and President at Autonomic Technologies, Inc. and President, North America at Thoratec Corporation. Prior to Thoratec, she served in progressively responsible global business development, strategy, and commercial roles at Johnson & Johnson. Pellegrini currently serves on the Board of Directors of Acutus Medical. She graduated from Santa Clara University with an MBA and a Bachelor of Science in finance.

 

6. Lena Hagman
Company: XVIVO
Title: Chief Operating Officer

In December 2022, Lena Hagman was appointed Chief Operating Officer of XVIVO, the first global all organ company. Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs — so transplant teams around the world can save more lives. Hagman has extensive global operational experience within the medical device industry, and has for the last 12 years been in different executive roles within the Getinge group, a Swedish global MedTech company. Her most recent role was as Executive Vice President for Quality compliance, Regulatory and Medical Affairs, which she held for 7 years.

Throughout her career, Hagman has been active in the medical device industry, with more than 20 years in leading positions with global responsibilities in R&D, supply chain, and quality/regulatory/medical affairs. Over the years, she has led many strategic and efficiency programs and company integrations. She has deep knowledge and experience in different global medical device quality regulations and with a high customer and patient centricity focus. She holds a Bachelor of Science in chemistry and textile engineering from Chalmers University of Technology, Sweden and is based at XVIVO’s headquarters in Gothenburg.

 

7. Jennifer Ernst
Company: Tivic Health
Title: Co-Founder and Chief Executive Officer

Jennifer Ernst is the Co-Founder and Chief Executive Officer of Tivic Health, a commercial phase healthtech company focused on advancing bioelectronic medicine. Ernst has more than 20 years of experience in the commercialization of breakthrough innovation and a history of developing markets from frontier technologies. As CEO of the U.S. subsidiary of Thin Film Electronics, she helped build the company from eight to 130 people, achieved a $480 million market cap in five years, and launched international award-winning products.

Ernst has held positions at Xerox PARC, positioning research for productization through strategic partnerships and licensing, and served as chairperson of Flex, the U.S. National Consortium for Flexible and Printed Electronics, now part of SEMI. She participated in the launch of the Global Women’s Leadership Network and was named to the Inc. Female Founders 100 and to the Healthcare Technology Report Top Women Leaders in Consumer Healthtech. She received an MBA from Santa Clara University and a Bachelor of Arts from San Francisco State University.

 

8. Manisha Shah-Bugaj
Company: Activ Surgical
Title: Chief Operating Officer

In December 2022, Manisha Shah-Bugaj was promoted from Activ Surgical’s Chief Operating Officer, a position she had held for just under a year, to its newest Chief Executive Officer. In addition to engaging with company partners, customers, and investors, Shah-Bugaj oversees the ongoing development and commercialization of Activ Surgical products, including ActivSight™ Intelligent Light, which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.

Prior to joining Activ Surgical, Shah-Bugaj architected the gynecology unit at Olympus from the ground up in the U.S., ultimately serving as General Manager and Global Vice President for the company, and played an integral role in expanding the gynecology business internationally. She has more than two decades of experience, including building and implementing corporate business plans, directing regional and global businesses aligned to financial and operational targets, hiring and establishing new teams, and managing product portfolios. She holds a Master of Engineering Management and a Bachelor of Engineering in biomedical engineering, both from Dartmouth College.

 

9. Anna Lucsok
Company: Zynex Medical
Title: Chief Operating Officer

Anna Lucsok currently serves as Chief Operating Officer for Zynex Medical. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. The company’s proprietary NeuroMove device is designed to help the recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.

Previously, Lucsok served as Vice President of Reimbursement and Sales Operations with Zynex. In this position, she was responsible for leading and expanding Zynex’s order, reimbursement, patient experience, and inside sales support operations. During her tenure, each of these teams consistently achieved quarterly targets, while also expanding in size. Lucsok brings more than nine years of healthcare operations experience as well as critical knowledge of revenue cycle management and medical care collections. She has been involved in various operations positions as well as management positions with Zynex since her start in 2018, including serving as Billing Manager. She previously held key positions with companies such as the University of Colorado Hospital, the U.S. Air Force based in Germany and Japan, and Schryver Medical. Lucsok holds certification in medical billing and earned her Bachelor of Science in healthcare administration and management from Colorado State University.

 

10. Sreelakshmi Kolli
Company: Align Technology
Title: Executive Vice President, Chief Digital Officer

Sreelakshmi Kolli is Executive Vice President Chief Digital Officer for Align Technology. She is responsible for leading software, data, enterprise, cloud, and infrastructure engineering teams focused on the design and development of digital products and services. This includes defining the technology strategy and development of product software, consumer, customer, manufacturing, and enterprise applications enabling the Align Digital Platform. In addition, Kolli led Align’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company.

Kolli joined Align in June 2003 as Manager, Software Engineering and held positions of increasing responsibility leading business operations and engineering for customer-facing applications. She was promoted to Senior Vice President, Global IT in December 2012 before being promoted to her current position in April 2020. Prior to joining Align, Kolli held technical lead positions with Citadon and Accenture. She is also a member of the Board of Directors at Zimmer Biomet Holdings, Inc. Kolli earned a Master of Science in computer applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business.

 

12. Deborah Gordon
Company: Insulet
Title: Vice President, Investor Relations

Deborah Gordon has served as Vice President, Investor Relations for Insulet Corporation since January 2015. Insulet is a roughly $1 billion medical device company dedicated to making the lives of people with diabetes easier through its OmniPod Insulin Management System. Gordon also serves on the Board of Directors of the L.S. Starrett Company, serving on the Audit Committee since July 2020 and the Compensation Committee since July 2021.

Prior to joining Insulet, Gordon served in a number of roles of increasing responsibility during her 10 years at Hologic, Inc. and Cytyc Corporation (which merged with Hologic in October 2007). Notably, she served for seven years as Hologic’s Vice President, Investor Relations and Corporate Communications and prior as Assistant Corporate Controller and Director of SEC Reporting and Technical Accounting at Cytyc. Before joining Cytyc, Gordon served in the audit practice at Deloitte & Touche for 11 years. She earned her Bachelor of Arts in business administration, with concentrations in accounting and economics, from Clark University and is a certified public accountant.

 

13. Suzanne Winter
Company: Accuray
Title: President and Chief Executive Officer

Since July 2021, Suzanne Winter has served as President of California-based medical equipment manufacturer Accuray, and in July 2022 she was promoted to Chief Executive Officer as well. In her position at the head of the company, Winter has continually driven the expansion of Accuray’s radiotherapy cancer treatment technologies, yielding record order volume and the approval of numerous novel treatments in China and beyond. She has had a significant impact on Accuray’s product portfolio and commercial momentum since joining the company.

Prior to joining Accuray, Winter held senior executive roles spanning general management, commercial operations, and business development across a range of healthcare industry segments, including radiology, neurology, and surgery. Most recently, she served as Group Vice President – Americas region at Medtronic Diabetes, where she was responsible for leading the 2,000 person commercial organization. Before Medtronic, Winter was the General Manager of GE Healthcare’s Detection and Guidance Solutions operations. She earned an MBA from Harvard Business School and a Bachelor of Science in chemistry from Saint Lawrence University.

 

14. Sandra Hirsch
Company: Zyris, Inc.
Title: President and Chief Executive Officer

Sandra Hirsch is the third founding member of Zyris, Inc., pairing decades of experience as a financial manager and CPA with a zeal for entrepreneurship sparked by her Bachelor of Science in business administration from the University of Southern California. Under her leadership as President and Chief Executive Officer, Zyris has grown from a struggling start-up to the world leader in dental isolation, distributing Isolite products throughout North America and in more than 20 countries overseas. Hirsch is defined by her family, the Zyris team, and unwavering resolve to forever change the experience of dentistry for patients and clinicians.

In 2001, Hirsch founded Innerlite Inc. with her husband Jim Hirsch, an industrial designer, and her brother-in-law Tom Hirsch, a practicing dentist. Together, they rebranded the company as Isolite Systems and launched their flagship product, the Isolite illuminated dental isolation system, in 2002. Isolite enables dental practices of all sizes to implement a technique for controlling the oral environment, providing an innovative solution for dental isolation. Offering a full line of isolation products that are minimally invasive and easy-to-use, Isolite Systems allows dental professionals to work more productively and effectively with less stress and fatigue for both themselves and their patients.

Today, Hirsch serves as President and CEO of Isolite Systems. Under her leadership, the company has grown from a single game-changing idea to an international phenomenon, with over fifty employees at their Santa Barbara-based manufacturing and distribution center and representatives worldwide. Thousands of dentists in over twenty countries are loyal fans of the safety, comfort, and control that Isolite dental isolation provides. In the U.S., over 20{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of all dental schools have adopted their products, which will soon become the standard of care for everyday dental procedures. Hirsch and the Isolite team continue to develop products that make a difference in people’s lives. They are relentlessly focused on the pursuit of a better dental experience for every patient and have earned numerous awards and accolades for their efforts.

 

15. Tavia Walsh
Company: Pulse Technologies
Title: Co-Founder Chief Technology Officer

Tavia Walsh is a Co-Founder and the Chief Technology Officer of Pulse Technologies, an entrepreneurial startup based in Vancouver designing innovative, low-cost consumer wearable devices using emerging new conductive materials and 3D printing methods. As a biomedical engineer with both an electrical and mechanical background, Walsh has an interest in complex problem solving and design thinking; and as a founder of Pulse, she has experience in the biomedical start-up space.

Walsh co-founded Pulse Technologies in 2016. While working on Pulse, she served as a biomedical engineer for 4M BioTech from 2020-2021 and as a mechanical engineer for ViVitro Labs Inc. from 2021-2022. Walsh earned her MD from University College Dublin, her Master of Applied Science in mechanical engineering from the University of Victoria, and her Bachelor of Applied Science from The University of British Columbia.

 

16. Jennifer Honeycutt
Company: Danaher
Title: Executive Vice President

As Executive Vice President, Jennifer Honeycutt provides strategic and operational leadership for Danaher’s Environmental and Applied Solutions businesses, which includes the Product Identification and Water Quality platforms. She also oversees Danaher’s High Growth Markets and regional teams outside of China. Honeycutt originally joined Danaher with the 2000 acquisition of Hach and has held positions of increasing responsibility across multiple industries over the past 20+ years.

Leadership roles at Hach Ultra Analytics, Anderson Instrument Company (now part of Fortive), Linx Printing Technologies, Beckman Coulter Life Sciences, and Pall have given her deep knowledge of the Danaher Business System (DBS) and a unique perspective on the many ways Danaher can help realize life’s potential across its businesses. Honeycutt is a champion of the power of diversity, and a longstanding member of Danaher’s Diversity + Inclusion Council. Throughout her tenure, she has consistently delivered strong results by building high-performing teams and driving strategic M&A, innovation, and commercial execution. Honeycutt earned a Master of Arts in Technology Management from the University of Denver and Bachelor of Arts degrees in chemistry and French from Grinnell College.

 

17. Pooja Pathak
Company: LumiraDx
Title: Chief Product Officer

Since June 2021, Pooja Pathak has served as Chief Product Officer for LumiraDx, a next-generation point of care diagnostics company based in the U.K. Founded in 2014, the company provides a comprehensive portfolio of testing solutions used by governments and leading healthcare institutions. Pathak, who previously served as LumiraDx’s Vice President of Platform Strategy, is currently responsible for product management, marketing, and medical affairs.

Prior to LumiraDx, Pathak most recently worked at Abbott as VP of Global Marketing for the Infectious Disease Emerging Markets business, which included 170 countries across Asia, EMEA, and Latin America. In this role she was responsible for a $500 million portfolio. Additionally, she has held leadership roles with Alere and Novartis Vaccines, where she focused on bringing new innovations to market, implementing integrated diagnostic and treatment programs, and rolling out global public health solutions. Pathak holds a Master of Science in chemical engineering from MIT and a Bachelor of Science in chemical engineering from the University of Illinois Chicago.

 

18. Kelli Howell
Company: Alphatec Spine
Title: Executive Vice President, Clinical Strategies

Kelli Howell has served as Executive Vice President, Clinical Strategies of Alphatec Spine since March 2018. Alphatec improves lives by providing innovative spine surgery solutions through its relentless pursuit of superior outcomes. The company is dedicated to the design, development, launch, and the delivery of spinal fusion products. Alphatec accomplishes this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. Its product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes.

For the 18 years prior to joining Alphatec, Howell held various management positions at NuVasive, Inc., including Vice President, Research & Health Informatics from January 2017 to March 2018, Vice President, Research & Education from February 2015 to January 2017, and Vice President, Research from April 2012 to February 2015. Prior to joining NuVasive, Howell was involved in research at Orthopedic Biomechanics Laboratory (OBL), Beth Israel Deaconess Medical Center in Boston. Howell received a Master of Science in biomedical engineering from Boston University and a Bachelor of Arts in engineering sciences from Dartmouth College.

 

19. Alison Burdett
Company: The Surgical Company
Title: Chief Scientific Officer

Alison Burdett has over 30 years of experience in electronic engineering and semiconductor design, particularly in the field of ultra-low-power wireless communication for medical applications. She co-founded Toumaz in 2001 and served as the Technical Director. She became the Chief Technical Officer in 2006, responsible for delivering silicon and advanced technology programs for both consumer and healthcare divisions of the business. In 2016, the healthcare business unit of Toumaz, Sensium Healthcare, became part of The Surgical Company Group and she joined Sensium, where she became the Chief Scientific Officer, responsible for all engineering and scientific programs for the company’s digital health products.

Prior to joining Toumaz, Burdett spent time both in industry as an integrated circuit designer, and also in academia (as a Senior Lecturer of Analog IC Design with Imperial College London). She is a Visiting Researcher with the Institute of Biomedical Engineering, Imperial College. She has more than 80 peer-reviewed publications and is a named inventor on more than 20 patents. Burdett was a member of the Technical Programme Committee for the IEEE International Solid-State Circuits Conference (ISSCC) from 2009 to 2018, serving as the European Regional Chair 2012–2014 and the Technical Program Chair for ISSCC 2018. She has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008, and is the Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems. She is a Chartered Engineer and a Fellow of the Institute of Engineering and Technology. Burdett earned her PhD in analogue IC design and her bachelor’s degree in electrical and electronics engineering from Imperial College London.

 

20. Rhonda Robb
Company: Cardiovascular Systems, Inc.
Title: Chief Operating Officer

From January 2018 to June 2022, Rhonda Robb served as Chief Operating Officer of Minnesota-based medical device manufacturer Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease. In her time at the company, Robb was renowned for her agile, forward-thinking leadership style, and her efforts helped bring the company to numerous new patients and a greatly expanded product line.

In the time since her departure from Cardiovascular Systems, Robb has continued to serve on the board of 4C Medical Technologies. Robb formerly served as Vice President and General Manager of the Heart Valve Therapies business at Medtronic. In that role, she was responsible for the transcatheter and surgical valve franchises. Previously, Robb held additional leadership positions in Medtronic’s Coronary, Peripheral, and Cardiac Rhythm businesses. She has strong experience leading complex businesses, growing new markets, extensive commercial experience, and a strong track record of building teams and product portfolios that have improved the quality of care for patients with cardiovascular disease. Robb holds an MBA from the University of Minnesota’s Carlson School of Management.

 

21. Jessica Lynch
Company: DentalMonitoring
Title: Chief Operations Officer – North America

Since April 2022, Jessica Lynch has been Chief Operations Officer – North America at DentalMonitoring, the leading Intelligent Platform globally which provides connected, smarter and more sustainable dental care. DentalMonitoring creates with doctors and partners an environment to deliver the best dental care to patients, synchronized with their treatment needs. Showcasing a unique, people-first leadership style, Lynch has helped the company improve financial results while enjoying sustainable organizational growth. Recent achievements by DentalMonitoring have included new advances in AI-driven dental technologies and a unique new gamified feature in its signature platform.

Prior to DentalMonitoring, Lynch served as Vice President of Operations Excellence and Vice President of Strategy for Smile Doctors. Before that, she was Chief Operating Officer for DN Orthodontics for four years. She also served as Senior VP, Doctor Relations (2010-2014) and Director of Operation Consultants (2009-2010) for OrthoSynetics, and was a physician liaison for Louisiana Medical Center and Heart Hospital, LLC. Lynch holds a Bachelor of Science in business administration from the University of Louisiana at Lafayette.

 

22. Rebecca Lin
Company: Potrero Medical
Title: Chief Strategic Officer

With her unique blend of business acumen and technical expertise, Rebecca Lin is a dynamic leader with many years of success in the healthcare industry. Today she serves as the Chief Strategic Officer for Potrero Medical, a Hayward, California-based predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence. Lin, who has been with the company since October 2016, previously served as the Senior Vice President of Sales and Marketing. In that role, she built and led the commercial organization that developed go-to-market strategies for Potrero’s Accuryn Monitoring System.

Over the years, Lin has achieved success at both large corporations and startups. Prior to her work at Potrero, she was the VP of Business Development at Theranova and led marketing initiatives for C. R. Bard (now owned by Becton Dickinson), in both Shanghai and the U.S. She has also worked as a Board Fellow at the American Red Cross Bay Area, currently serves as a guest lecturer at the University of California, San Francisco and Berkeley, and spent several years in sales and training at Johnson & Johnson. Lin holds a Master of Science in management from the Stanford University Graduate School of Business and a master’s in marine biology from Sun Yat-sen University in Guangdong, China.

 

23. Kristie West
Company: Orchid Orthopedic Solutions
Title: Chief Operating Officer

Kristie West is the Chief Operating Officer at Orchid Orthopedic Solutions, a global leader in medical device outsourcing services. Founded in 2005, the company’s 1,500 employees work to provide a broad array of capabilities in the world of orthopedic devices, including design, regulatory affairs, implant manufacturing, and instrument manufacturing, among other areas. West, who is a Six Sigma Black Belt and a Master Black Belt, joined Orchid in January 2022.

West came to Orchid from General Electric’s Edison Works Programs and Operations team, where she was the Senior Executive Director supporting the future of military combat and space. Prior to joining the Edison Works team, West was the Senior Executive for the Tubes & Ducts Value Stream in GE Aviation’s Supply Chain organization. She also held a number of leadership roles within GE, including Director of Operations for Unison Industries (a GE company); Executive Plant Leader for Avio Aero (a GE company), in Torino, Italy; Supply Chain Strategy Leader for GE Aviation; and CF6 Customer Programs Leader. Prior to GE, West held various leadership roles in manufacturing with Navistar and Carrier Global Corporation. She holds a Bachelor of Science in organizational leadership from Purdue University’s Polytechnic Institute.

 

24. Liz Hammack
Company: Pristine Surgical
Title: Chief Manufacturing Officer

Liz Hammack is Chief Manufacturing Officer of Pristine Surgical, a medical device company with a mission to simplify endoscopy. While Hammack joined the company in September 2021, her career began more than 30 years ago. During this time, she has worn many hats: from working on the factory floor, to holding multi-plant leadership, to operating in the boardroom. In addition to her work at Pristine, she is also the principal owner of Hammack Manufacturing Solutions, which is based in Portland, Oregon.

Prior to Pristine, Hammack spent 16 years at Medtronic, most recently serving as a Vice President of Manufacturing and Operations, AFS. In that position, she led operations, manufacturing, and supply chain integration activities for the newly formed AF Solutions business at Medtronic-CRDM. In 1981, she graduated from Oregon State University with a Bachelor of Science in industrial engineering. A proud alum, she has since served on numerous boards for the university’s College of Engineering. Furthermore, in 2013, she received Oregon State’s distinguished engineer award.

 

25. Dina Dubey
Company: Teleflex
Title: Chief Operating Officer

Dina Dubey is the Chief Operating Officer of Teleflex. Dubey’s roots with the company go back to 2011, when she started off as Director of Research and Development for Z-Medica, which was acquired by Teleflex in 2020. In this position, Dubey drove a pipeline of projects and developed and drove QuikClot Control+, the organization’s first-of-its-kind, new-generation hemostatic dressing, which ultimately resulted in commercialization of the product. On top of that, Dubey was a vital member of the executive leadership team that grew Z-Medica’s revenue from $28 million to $64.8 million.

Dubey started her career at Kensey Nash Corporation (now DSM Biomedical), where she spent eight years in engineering and management roles. In 2003, she received a Bachelor of Science in biomedical engineering from Case Western Reserve University. She also holds a Master of Science in engineering management and a Master of Science in biomedical engineering from Drexel University. More recently, Dubey completed a leadership development program from Harvard Business School Executive Education.

Medical Devices Secondary Packaging Market is Estimated to be Valued at US$ 12,409.8 Million in 2023 & Rising to US$ 20,914 Million by 2033

Medical Devices Secondary Packaging Market is Estimated to be Valued at US$ 12,409.8 Million in 2023 & Rising to US$ 20,914 Million by 2033
Future Market Insights Global and Consulting Pvt. Ltd.

Future Market Insights Global and Consulting Pvt. Ltd.

Leading Medical Devices Secondary Packaging Market participants include Sonoco Products Company, Smurfit Kappa, Berry Global Group, Inc., Constantia Flexibles Group GmbH, UFP Technologies, Placon Incorporated, Steripack Group among others. China’s Medical Devices Secondary Packaging Market is projected to be worth US$ 1,270.1 million by 2033.

NEWARK, Del, Feb. 14, 2023 (GLOBE NEWSWIRE) — The global medical device secondary packaging market is expected to be worth US$ 12,409.8 million in 2023, rising to US$ 20,914 million by 2033. The adoption of medical device secondary packaging is expected to surge at a stable CAGR of 6.1{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} over the forecast period.

The medical device secondary packaging market is experiencing significant growth driven by several key factors. The increasing aging population and the associated rise in chronic diseases are driving the demand for medical devices such as pacemakers, stents, and artificial joints, leading to an increased need for proper packaging to ensure the safety and integrity of these devices. Advancements in medical technology have also led to the development of new medical devices, requiring manufacturers to invest in packaging solutions to protect them during transportation and storage.

In addition, the growing demand for minimally invasive surgical procedures is driving the need for smaller medical devices and appropriate packaging solutions to ensure safe delivery to the surgical site. Stringent regulations for medical device secondary packaging are also playing a key role in driving demand as governments around the world implement standards to protect the safety and integrity of the devices.

Request a Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16617

Furthermore, rising awareness about the importance of proper packaging in extending the shelf life of medical devices is also driving demand.

While the adoption of medical device secondary packaging is expected to experience significant growth, manufacturers are also facing several challenges. One of the prominent challenges is meeting stringent regulations and compliance requirements to ensure the safety and integrity of medical devices. Another challenge is ensuring the compatibility of packaging materials with medical devices to avoid any damage. Managing costs while maintaining high standards of quality is also a significant challenge for manufacturers as they strive to produce packaging solutions at a competitive price while meeting industry standards.

Key Takeaways from the Medical Device Secondary Packaging Market:

  • The paper and paperboard market is predicted to account for US$ 14,293.2 million by 2032 and to grow at a 5.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} CAGR throughout the projection period.

  • During the projection period, the plastic segment is expected to offer a growth potential of US$ 6,620.8 million. In 2022, the boxes sector accounted for about 30{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the market. This category is also predicted to rise at a healthy 5.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} CAGR throughout the projection period.

  • Folding cartons are expected to represent an incremental potential of US$ 1.9 billion over the projection period and to account for more than 21{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the market by 2032.

  • During the projection period, the medical device secondary packaging sector in the United States is expected to exceed US$ 5,067.6 million.

  • This German market is predicted to provide a startling additional opportunity of US$ 1,030.4 million, making it an appealing location for both investors and producers.

  • By 2032, China’s medical device secondary packaging industry is expected to be worth US$ $1,270.1 million.

Who is Winning?

Product innovation, market expansion into new markets, strategic alliances and collaborations, and acquisitions are common growth tactics employed by the industry’s leading players. Startups in the market are developing innovative technologies to efficiently label medical devices.

Packaging companies may save validation time and eventually create smaller batch sizes that comply with customer specifications by applying the same processes for identical medical devices with a few minor adjustments. The use of NFC and RFID tags in packaging materials is expected to be promoted by counterfeiting, which is a serious problem with medical supplies.

Sonoco Products Company, Smurfit Kappa, Berry Global Group,Inc., Constantia Flexibles Group GmbH, UFP Technologies, Placon Incorporated, Steripack Group, Nelipak Group, Stora Enso Oyj, Winpak Ltd, Graphic Packaging International, LLC,Atlantic Packaging, Pro-tech Design & Manufacturing Inc., Scan Modul B.V., Körber AG, The BoxMaker

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16617

Recent Developments in the Market:

  • Ashfield, a subsidiary of UDG Healthcare plc, announced the development of three business divisions in January 2021 to expand and diversify its healthcare capabilities.

  • In April 2021, Amcor presented its most recent invention, the New AmSkyTM blister system. This innovation has the potential to revolutionize medical packaging sustainability.

  • In April 2020, Amcor’s ULTRA pouches were certified for steam sterilization at 134°C and vaporized hydrogen peroxide treatment. As a result, the pouches may be used to sterilize reusable medical equipment.

Medical Devices Secondary Packaging Market by Category

By Material:

  • Paper and Paperboard

  • Plastics

By Packaging Format:

  • Boxes

  • Folding Cartons

  • Bags and Pouch

  • Trays

  • Inserts and Dividers

  • Wrapping Films

By End Use:

  • Surgical

  • Therapeutic

  • Diagnostic

By Region:

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-16617

Table of Content

1. Executive Summary | Medical Devices Secondary Packaging Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

Browse Full Report@ https://www.futuremarketinsights.com/reports/medical-devices-secondary-packaging-market

Have a Look at Related Research Reports of Packaging

Packaging Tapes Market Size: The global packaging tapes market is set to enjoy a market valuation of US$ 71.7 Bn in 2021, and register a CAGR of 4.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} {08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} to reach US$ 120.1 Bn by 2032.

Packaging Bins Market Forecast: Global sales of packaging bins stood at around US$ 1.9 Bn in 2021 and is slated to increase at a CAGR of 4.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} to reach a valuation of US$ 3.0 Bn by 2032.

FMCG Packaging Market Outlook: The global FMCG packaging market is expected to reach US$ 418.8 Bn in 2022, with sales growing at a CAGR of 5.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} through 2032.

Medical Device Packaging Market Sales: The global medical device packaging market is likely to reach US$ 48.1 Bn by the year 2027at a CAGR of 5.3 {08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} between 2022 and 2027.

Medical Device Trays Market Growth: Medical Device Trays Market: Medical Device Trays Industry Analysis, Regional Outlook, Market Revenue, Competitor Analysis, and Industrial Growth by Future Market Insights.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

Foundation named for Laurie Melchionda donates medical equipment

Foundation named for Laurie Melchionda donates medical equipment

BRAINTREE − Defibrillators for city structures and products for the nurse’s office environment at the new South Center College will be donated to the city by a foundation commenced in memory of a slain member of the board of wellbeing who was a longtime university nurse.

The $15,000 donated to pay out for the nurse’s business office furnishings and 5 defibrillators for town and school buildings is from the Laurie Melchionda Foundation. The city council voted unanimously to accept them at Tuesday night’s assembly.

Foundation named for Laurie Melchionda donates medical equipment

Melchionda was a nurse at Boston Kid’s Medical center for 35 yrs and a nurse in the Braintree educational institutions for 25 many years in advance of leaving to develop into the director of nursing for the Weston educational institutions. She was shot and killed at her Howie Highway household in June 2020. The man billed with the criminal offense is a former neighbor who posed as a supply driver.

Globus Medical, NuVasive to merge

Globus Medical, NuVasive to merge

Globus Medical NuVasiveGlobus Health-related (NYSE:GMED) and NuVasive (Nasdaq:NUVA) today introduced an settlement to mix in an all-inventory transaction.

The deal values NuVasive at $3.1 billion, with Globus shareholders owning around three-fourths of the recently merged enterprise.

BTIG analysts raised the question of likely anti-have confidence in troubles for the deal, which would make the next-premier backbone tech firm at the rear of Medtronic.

“We accept that the spine market place is very aggressive, with a quantity of providers (100+), but in the present-day natural environment, we imagine it will weigh on investors’ minds. Management could only say that the attorneys are reviewing anything at this point,” reported Ryan Zimmerman and Sam Durno at BTIG.

Shares of GMED dropped extra than 16{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} at $64.57 apiece in early morning investing. NUVA shares rose more than 4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} at $47.93 apiece. MassDevice‘s MedTech 100 Index, which features stocks of the world’s biggest healthcare unit organizations, was up extra than 12{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}.

Turning out to be the major musculoskeletal technological innovation company in the globe

The two musculoskeletal technologies firms share a vision concentrated on improving individual treatment, according to a news launch. By yearly income, NuVasive and Globus Healthcare are already the No. 7 and No. 8 major orthopedic device corporations in the environment, respectively.

Under the phrases of the settlement — which both equally companies’ boards unanimously accredited — NuVasive shareholders receive .75 of a share of Globus Course A frequent stock for each and every share of NuVasive frequent inventory owned at closing. Based on the exchange ratio, the implied share price for NuVasive totals $57.72. That quantities to an fairness price of $3.1 billion.

Pursuing the closing of the transaction, 28{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of ownership goes to NuVasive shareholders. Meanwhile, the remaining 72{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} belongs to Globus shareholders on a fully diluted basis.

NuVasive CEO Chris Barry explained the businesses share “complementary abilities, geographic footprints and purchaser bases.”

“This transaction displays our mission to turn out to be the primary musculoskeletal technological innovation enterprise in the earth by creating merchandise that market healing in people with musculoskeletal issues,” reported Dan Scavilla, president and CEO of Globus Professional medical. “With NuVasive, we can aid assist much more clients via major innovation and growing our professional attain to deliver excellent assistance to our surgeon and healthcare facility partners. We look ahead to combining the NuVasive and Globus Professional medical groups to capitalize on the many prospects to boost patient care and produce sustainable shareholder worth.”

Globus, NuVasive lay out the advantages of their mixture

The companies mentioned the transaction accelerates their tactics to focus on the $50 billion musculoskeletal marketplace. That incorporates backbone, orthopedics, enabling technological know-how, electric power applications, biologics and more.

Globus and NuVasive deliver a merged existence in far more than 50 nations with more than 5,000 personnel. They come to feel a more substantial profits firm permits more penetration into current and future marketplaces.

Moreover, Globus and NuVasive reported their complementary products enable the generation of a thorough, impressive portfolio. They also just about every provide “respective operational rewards,” including Globus’ manufacturing ability and NuVasive’s distribution networks.

Other advantages include things like upside profits possible and powerful money profiles and price creation opportunities.

How the merged firm would work

Upon closing, the blended corporation is set to feature an 11-member board. It consists of all 8 administrators from Globus’ board and 3 from NuVasive’s.

The arrangement sees David Paul, Globus board chair, set to serve as chair of the put together company’s board. Scavilla usually takes on the position of CEO, although the corporation picked Globus CFO Keith Pfeil for the similar function at the blended organization.

NuVasive CEO Chris Barry “will assistance integration organizing of the mixed organization.”

Timeline and monetary outlook

Globus and NuVasive anticipate the transaction to shut in the middle of this calendar year. It stays matter to shareholder approval from both equally sides, regulatory acceptance and other customary circumstances.

The two companies confirmed preliminary fiscal year-conclusion final results as section of the merger announcement. Globus assignments 6.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} gross sales growth and NuVasive anticipates 5.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} income advancement for the full year.

Ahead of 2023, Globus expects to enhance gross sales by at minimum 7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} and NuVasive expects to grow by at the very least 6{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}.

 

Best glucometer

Best glucometer

Which glucometers are finest?

Thousands and thousands of Us citizens dwell with diabetic issues and rely on a glucometer to evaluate their blood glucose ranges. Glucometers consider a blood sample to an enzyme electrode and mix it with a glucose oxidase enzyme. Then an electrical recent measures the amount of resistance and delivers a examining. This will help folks with diabetic issues know if their ranges are too high or very low, which would have to have insulin or ingesting sugar, respectively.

Due to the fact a glucometer is employed each day for this kind of an critical intent, locating the suitable just one is critical for handling your diabetic issues. For a comprehensive start with a glucometer, check strips and lancets, the Ascensia Contour Following Blood Glucose Monitoring Technique All-in-One particular Package is the top rated preference.

What to know before you purchase a glucometer

Glucometer sizes

There are several sizes of glucometers. Some are significant, resembling the dimension of a smartphone, all around 2 by 3 inches. Others are more compact, a little bit even larger than a laptop flash drive, about 1 by 2 inches. Choose wherever you program to carry your glucometer and ascertain which sizing is greatest for you. What is most critical is to make sure the carrying situation consists of check strips and a lancet for your upcoming measurement.

Coding

Since companies use their possess examination strips with their glucometers, test strips arrive with a code that demands to be entered into the meter for it to get the job done adequately with a new batch of take a look at strips. There are more recent glucometers that no for a longer period demand coding or read the code immediately, saving time in the tests process. Look at your manufacturer’s requirements for coding. 

Quantity of blood

The fewer blood you have to supply, the greater. Lots of glucometers call for 3-tenths to six-tenths of a microliter of blood. Seem for meters and examination strips that involve the minimum amount of blood.

What to search for in a high quality glucometer

Precision

Glucometers are reviewed by the U.S. Food items and Drug Administration, so their accuracy is held to the maximum common for clinical gadgets. This is important due to the fact consumers are building selections about no matter if to maximize their sugar ingestion for hypoglycemia or to choose insulin for hyperglycemia. Even even though all are Food and drug administration-accepted, test benefits can differ somewhat.

Information storage

You and your doctor should overview your blood glucose trends to decide how most effective to regulate your diabetic issues. Knowing how your physique is responding to training, diet and medication, and even what time of working day your stages boost, is important for making your treatment method system. Appear for glucometers that can shop your readings in excess of a lengthy period, this kind of as a week. This data can frequently be downloaded at your doctor’s office environment.

Bluetooth

Newer glucometers can add your readings to a smartphone app that can hold the data for your future doctor’s appointment and also present you with true-time updates about your most up-to-date trends.

How substantially you can count on to devote on a glucometer

They operate from $10-$100, dependent on capabilities. Relieve of use and accuracy are essential, so glance for those first, within just your price range.

Glucometer FAQ

Do glucometers arrive with examination strips?

A. Several arrive with an preliminary provide of test strips, but you’ll eventually need to buy far more. They can be costly, but a lot of coverage organizations include a part of this value. Test your strategy to figure out how significantly coverage you have.

What else can I do to much better handle my diabetes?

A. Routinely see your medical professional and stick to their information. Also be positive to see your dentist and eye treatment experienced for frequent tests, because diabetes can have an affect on enamel and eyes, too. Workout according to your doctor’s tips and limit your consumption of synthetic sweeteners and carbohydrates. Look at an insulin pump if you are going to be owning recurring injections.

What’s the best glucometer to purchase?

Prime glucometer

Best Ascensia Contour Next Blood Glucose Monitoring System All-in-One Kit

Ascensia Contour Upcoming Blood Glucose Checking Process All-in-A single Kit

What you require to know: This entire starter package arrives with every thing you need to have, all when giving fast, exact success.

What you will like: In addition to a compactly created meter, this package arrives with 20 examination strips and 10 lancets, a handbook and a carrying scenario. Affordable and accurate, there is no coding, and the glucometer has alarm reminders. An 18-month warranty on all pieces is provided.

What you should really take into account: Some inaccurate readings have been described. The console is a little bit a lot more complicated than some others in this sequence.

The place to buy: Sold by Amazon

Major glucometer for the revenue

On Call Express Diabetes Testing Kit

On Call Specific Diabetic issues Tests Kit

What you need to know: This inexpensive kit presents success in just a few seconds.

What you will really like: It has a massive, effortless-to-examine display screen, and success appear in four seconds. It is backed by a 5-year warranty and 24/7 buyer service.

What you really should think about: Calibration of the glucometer can be complicated but is required.

Exactly where to buy: Bought by Amazon

Well worth checking out

Freestyle Freedom Lite Blood Glucose Monitoring System

FreeStyle Freedom Lite Blood Glucose Monitoring System

What you need to have to know: This package is modest, rapid and accurate, from a reliable manufacturer.

What you’ll like: It arrives with a smooth-styled glucometer, lancet, lancing supplies and a guide. It’s incredibly rapid and fairly accurate.

What you need to take into consideration: The kit does not arrive with check strips, and the exam strips for it can be pricey.

Wherever to obtain: Offered by Amazon 

Want to store the most effective solutions at the ideal charges? Look at out Every day Offers from BestReviews.

Sign up right here to acquire the BestReviews weekly newsletter for handy information on new products and noteworthy discounts.

Steve Ganger writes for BestReviews. BestReviews has helped thousands and thousands of buyers simplify their paying for selections, conserving them time and income.

Copyright 2023 BestReviews, a Nexstar corporation. All rights reserved.

New 3M tape for wearable medical devices can now stick up to 28 days

New 3M tape for wearable medical devices can now stick up to 28 days

3M has introduced a new adhesive tape that can stick to the skin for up to 28 days for use with medical monitors, sensors and wearables — a significant improvement over the industry’s standard wear time.

The company is marketing the tape to medical device makers and original equipment manufacturers.

Known to consumers as the maker of Scotch tape and Post-it notes, 3M has more than 55 years of medical adhesion experience. The company produces more than 200 medical tapes and films.

“If you think of a Post-it note, you want to be able to remove it without damage to whatever you’ve stuck it to. You think of skin in the same way,” said Chad Reed, director of global business for 3M medical materials and technologies. “You want to stick something to the skin and be able to remove it without damage to the skin.”

The target market is wearable medical devices, for example, glucose monitors.

As device manufacturers work through developing a new device, they will incorporate the 3M adhesive, which can be worn in wet conditions, and will not fall off due to sweat.

“It is usually a patch,” Reed said. “Most patients won’t have any idea that a 3M product is incorporated into that device.”

Before last year, the industry standard wear time for medical adhesives was up to 14 days. In April 2022, 3M debuted an adhesive — 3M Medical Tape 4576 — that could last for up to 21 days. 3M developers in the U.S. and Japan spent about a year devising that longer-lasting adhesive.

The newest adhesive is 3M Medical Tape 4578, which can last for up to 28 days.

“This is a huge innovation,” said Michael Fry, senior principal product engineer with St. Paul-based Minnetronix Medical, a contract manufacturer of medical devices. “Longevity of the adhesive is an important factor. It really helps to lessen the intrusion on the patient’s life.”

Minnetronix currently has six wearable products under development and production. Patients with wearables using the new tape will not need to switch patches as often. As a result, Fry said, it could cut costs for device development because fewer patches will be needed.

It may also improve patient safety, he said. For a patient with an open wound under a wearable, fewer changes means lower risk of contamination.

A recent study from Deloitte found that 49{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of U.S. health care consumers use wearables, digital assistants or smart devices to track health and fitness.

“About one-third of consumers said they use a wearable device to monitor health issues — for example, blood sugar, blood pressure, breathing function, mood,” wrote Glenn Snyder, Deloitte’s global med tech practice leader, in a November blog post.

In July, 3M announced plans to spinoff its $8.6 billion health care business into a separate public company. It expects to complete the separation by the end of this year. The company has not shared new details or an updated timeline since announcing the plan.